KaneNRikardRMcCroryKMarxA. Crushed posaconazole delayed-release tablets via enteral feeding tubes: a cautionary tale [published online ahead of print April 30, 2024]. Ann Pharmacother. doi:10.1177/10600280271249705.
2.
CumpstonACaddellRShillingburgA, et al. Superior serum concentrations with posaconazole delayed-release tablets compared to suspension formulation in hematological malignancies. Antimicrob Agents Chemother. 2015;59(8):4424-4428. doi:10.1128/AAC.00581-15.
3.
DuraniUToshPBarretoJNEstesLLJannettoPJTandeAJ.Retrospective comparison of posaconazole levels in patients taking the delayed-release tablets versus the oral suspension. Antimicrob Agents Chemother. 2015;59(8):4914-4918. doi:10.1128/aac.00496-15.
4.
ManeshADevasagayamEBhanuprasadK, et al. Efficacy of crushed delayed-release posaconazole tablets in rhino-orbital-cerebral mucormycosis. Antimicrob Agents Chemother. 2022;66:e0108522. doi:10.1128/aac.01085-22.
5.
DieringerTDSchaenmanJMDavisMR.Enteral feeding tube administration with therapeutic drug monitoring of crushed posaconazole tablets and opened isavuconazonium sulfate capsules. J Antimicrob Chemother. 2022;77:1417-1423. doi:10.1093/jac/dkac035.
6.
StevensRWO’ConnellCHuangAEppsKLIlgesD.Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes. J Antimicrob Chemother. 2023;78(2):553-555. doi:10.1093/jac/dkac427.
7.
BioLLHiroshimaLSchwenkHTGreenS.Successful enteral administration of crushed posaconazole delayed-release tablets in children. Pediatr Blood Cancer. 2024;71(2):e30782. doi:10.1002/pbc.30782.
8.
PrayagPSPanchakshariSPMahalleNP, et al. Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India. Int J Infect Dis. 2022;124:76-80. doi:10.1016/j.ijid.2022.09.004.
9.
EzzetFWexlerDCourtneyRKrishnaGLimJLaughlinM. Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations. Clin Pharmacokinet. 2005;44(2):211-220. doi:10.2165/00003088-200544020-00006.
